Utrecht, March 2021

Approximately 3000 patients measured with DeltaScan

With the consortium partners (UMC Utrecht, Charité and UZ Leuven and Key Opinion Leaders (Prof Slooter, NL; Prof Spies, DE; Prof Milisen, BE), the international CLEO evaluation study with the purpose to evaluate DeltaScan in daily practice was severely hampered by the COVID-19 pandemic, which made it not possible to reach the required inclusion numbers in the intervention phase of the study. Study sites did however get a good introduction to DeltaScan and most continue to use DeltaScan after their participation in the study.
Other positive achievements of CLEO are: 
– Some 3000 patients in ICUs, cardiothoracic surgery ward and geriatric traumatology wards
  in the Netherlands, Germany and Belgium were measured several times with DeltaScan 
– on all participating departments the awareness for delirium has risen due to the study participation and
  presentations we gave
– thousands of nurses made our e-learning Delirium and e-learning DeltaScan
– hundreds of doctors made our e-learning Delirium and e-learning DeltaScan 
– thousands of nurses performed measurements with DeltaScan